Skip to content

Perineal Reconstruction Following eLAPE and Simultaneous Stoma Sublay Reinforcement

Perineal Reconstruction Following Extralevator Abdominoperineal Excision of Rectum and Simultaneous Stoma Sublay Reinforcement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01670851
Acronym
PRESSUR
Enrollment
20
Registered
2012-08-22
Start date
2013-03-31
Completion date
2015-09-30
Last updated
2015-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

eLAPE,, perineum,, pelvic floor reconstruction

Brief summary

This is a prospective, multicenter, single arm, observational pilot study to assess the clinical outcomes of Strattice Reconstructive Tissue Matrix for perineal reconstruction following eLAPE and simultaneous stoma reinforcement.

Detailed description

About 40 subjects will be enrolled from 4 centers over approx 24 months. Subjects will all be undergoing extralevator abdominoperineal excision with concomitant ostomy creation.

Interventions

DEVICEStrattice

Perineal reconstruction and stoma reinforcement with Strattice

Sponsors

Karolinska University Hospital
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CollaboratorOTHER
Slagelse Hospital
CollaboratorOTHER
University Hospitals, Leicester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary cancers undergoing curative surgery (R0) * Life expectancy \> 2 yrs * Neoadjuvant radiotherapy with or without chemotherapy

Exclusion criteria

* Pelvic extenteration or extended resections * Previously irradiated patients (i.e. radiation therapy for a previous cancer) * Co-morbidities of: systemic infection, chronic liver failure, chronic renal failure, HIV, Hepatitis C, other advanced/metastatic cancer, collagen disorder * sensitivity to porcine derived products or polysorbate

Design outcomes

Primary

MeasureTime frameDescription
Perineal wound healing12 monthsPerineal wound healing will be assessed using the Southamptom Wound Scoring System and perineal pain assessed using a visual analogue scale (VAS) daily during hospital stay and then POD 7, 30 and months 3, 6 and 12.

Secondary

MeasureTime frameDescription
Incidence of perineal herniation24 monthsIncidence of perineal hernia
Incidence of parastomal hernia24 monthsStoma will be assessed for herniation at Months 3, 6, 12 and 24

Countries

Denmark, Sweden, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026